MSI2 is dysregulated in both chronic and acute hematopoietic malignancies; MSI2 expression is increased in blast crisis CML compared to chronic-phase CML [78]. The gene discussed is MSI2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.